HomeInsightsMarket Capitalization

Market Capitalization of Themis Medicare Ltd

Market Capitalization of Themis Medicare Ltd

stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

31.8 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Themis Medicare Ltd

NSE: THEMISMED

MARKETCAP

2379.7 crore

Last updated: 18 Sep 24

Key Highlights

  • The Market Cap of Themis Medicare Ltd is ₹ 2379 crore as of 18 Sep 24.
  • The Market Cap of Themis Medicare Ltd changed from ₹ 272.17 crore on March 2019 to ₹ 2015 crore on March 2024 . This represents a CAGR of 39.61% over 6 years. .
  • The Latest Trading Price of Themis Medicare Ltd is ₹ 258.55 as of 18 Sep 15:30.

Historical Market Cap of Themis Medicare Ltd

No data available

* All values are in crore

Company Fundamentals for Themis Medicare Ltd

No data available

Image

Themis Medicare Ltd

NSE: THEMISMED

PRICE

258.55

-16.95 (-6.15%)

stock direction

Last updated: 18 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Themis Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024258.55
17 Sep 2024275.5
16 Sep 2024279.2
13 Sep 2024268.95
12 Sep 2024275.05
11 Sep 2024248.05
10 Sep 2024249.8
09 Sep 2024241.45
06 Sep 2024239.25
05 Sep 2024248.35

SWOT Analysis Of Themis Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Themis Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Themis Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Themis Medicare Ltd

No data available

Historical P/E Ratio of Themis Medicare Ltd

No data available

* All values are in %

Historical Revenue of Themis Medicare Ltd

No data available

* All values are in crore

Historical EBITDA of Themis Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Themis Medicare Ltd

No data available

* All values are in crore

Historical Dividend Payout of Themis Medicare Ltd

No data available

* All values are in %

About Themis Medicare Ltd

  • Incorporated in 1969, Themis Medicare Ltd., formerly known as Themis Chemicals (TCL) was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April 93.
  • The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
  • In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.
  • Total cost of the project was estimated at Rs 17.

Themis Medicare Ltd News Hub

News

Themis Medicare to hold board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 20...

Read more

17 Jul 202409:49

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

15 May 202410:44

News

Themis Medicare schedules AGM

Themis Medicare announced that the 54th Annual General Meeting(AGM) of the company will be...

Read more

15 May 202410:44

News

Themis Medicare announces board meeting date

Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 May 202...

Read more

04 May 202410:14

News

Themis Medicare announces board meeting date

Themis Medicare will hold a meeting of the Board of Directors of the Company on 10 Februar...

Read more

30 Jan 202415:36

News

Themis Medicare launches novel Opioid Injectable Analgesic REMIFENTANIL

Themis Medicare announced the launch of a novel Opioid Injectable Analgesic REMIFENTANIL u...

Read more

10 Nov 202319:10

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Themis Medicare Ltd

What is the market cap of Themis Medicare Ltd?

As of September 18, 2024, Themis Medicare Ltd has a market capitalization of ₹2379.7, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Themis Medicare Ltd's market capitalization?

Themis Medicare Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Themis Medicare Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Themis Medicare Ltd's market capitalization change?

Themis Medicare Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*